The Coronary Calcium Study, or “CorCal” for short, is seeking to find the best way to test for coronary heart disease. Intermountain Healthcare is testing the effectiveness of standard heart disease prevention practices compared to screening for calcium build up in the arteries of the heart.
Participation in the CorCal Study is voluntary and by invitation only. Invitation letters were sent to patients of Intermountain physicians who are participating in this study, and who’s patients qualify based on risk factors identified in their medical records.
The following video provides information about the CorCal study and must be fully watched by each participant in the study prior to being enrolled.
Why is this study important?
Heart Disease is the single largest killer of American males and females. About one-third of all heart-related deaths happen in patients with no warning symptoms.
How do we test for coronary heart disease now?
The American Heart Association (AHA) standard is to test your cholesterol through a blood test called a “lipid panel”. Cholesterol levels are used with other information in your health record to determine your risk of developing heart disease in the next 10 years.
What methods of testing is this study evaluating?
This study is evaluating the effectiveness of combining normal cholesterol testing with a CT scan of your heart. A CT is a machine that takes an image of any calcium build up that may be in the arteries of your heart. Calcium build up means that plaque is present which can lead to a heart attack or stroke.
The Frequently Asked Questions page may also provide answers to any additional questions you may have about the study.